TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 10, 2008, Pages 1186-1189

  Weihl, C C ^a   Temiz, P ^b   Miller, S E ^a   Watts, G ^c   Smith, C ^d   Forman, M ^e   Hanson, P I ^a   Kimonis, V ^f   Pestronk, A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; TDP 43; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; CYTOPLASM; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INCLUSION BODY MYOPATHY; INCLUSION BODY MYOSITIS; MUSCLE; MUSCLE CELL; MYOPATHY; PATHOGENESIS; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATASES; ANTIGENS, CD8; CELL CYCLE PROTEINS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; ELECTROMYOGRAPHY; HUMANS; MUSCLE, SKELETAL; MUTATION, MISSENSE; MYOSITIS, INCLUSION BODY; PHOSPHORYLATION; POINT MUTATION;

EID: 53149138951     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.131334     Document Type: Article

References (17)

1. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-3.
2. Yokoseki A, Shiga A, Tan CF, et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 2008;63:538-42.
3. Giteho MA, Baloh RH, Chakraverty, et al. TDP-43 A3IST mutation in familial motor neuron disease. Ann Neurol 2008;63:535-8.
4. Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008;40:572-4.
5. Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008;319:1668-72.
6. Forman MS, Mackenzie IR, Cairns NJ, et al. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neumpathol Exp Neurol 2006;65:571-81.
7. Neumann M, Mackenzie IR, Cairns NJ, et al. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neumpathol Exp Neurol 2007;66:152-7.
8. Hubbers CU, Clemen CS, Kesper K, et al. Pathological consequences of VCP mutations on human striated muscle. Brain 2007; 130:381-93.
9. Askanas V, Engel WK. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 2006;66(Suppl 1):S39-48.
10. Askanas V, Alvarez RB, Engel WK. beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol 1993;34:551-60.
11. Askanas V, Engel WK, Bilak M, et al. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol 1994; 144:177-87.
12. Dalakas MC. Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006;2:437-47.
13. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosincontaining protein. Nat Genet 2004;36:377-81.
14. Weihl CC, Dalai S, Pestronk A, et al. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum Mol Genet 2006;15:189-99.
15. van der Meulen MF, Hoogendijk JE, Moons KG, et al. Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis. Neuromuscul Disord 2001;11:447-51.
16. Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998;18:164-7.
17. Calado A, Tome FM, Brais B, et al. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 2000;9:2321-8.